Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0OC6H
|
||||
| Former ID |
DIB011692
|
||||
| Drug Name |
S-024
|
||||
| Synonyms |
Chk1 inhibitors (cancer); S-024; S-144; Chk1 inhibitors (cancer), Sentinel
|
||||
| Indication | Cancer [ICD9: 140-229; ICD10:C00-C96] | Investigative | [543531] | ||
| Company |
Sentinel Oncology Ltd
|
||||
| Canonical SMILES |
C[N+](C)(CCCOc1c(NC(=O)Nc2cnc(cn2)C#N)cc(cc1)Cl)[O-]
|
||||
| Target and Pathway | |||||
| Target(s) | Serine/threonine-protein kinase Chk1 | Target Info | Inhibitor | [543531] | |
| Pathway Interaction Database | Fanconi anemia pathway | ||||
| p73 transcription factor network | |||||
| ATR signaling pathway | |||||
| Circadian rhythm pathway | |||||
| p53 pathway | |||||
| Reactome | Activation of ATR in response to replication stress | ||||
| Processing of DNA double-strand break ends | |||||
| Presynaptic phase of homologous DNA pairing and strand exchange | |||||
| G2/M DNA damage checkpoint | |||||
| Ubiquitin Mediated Degradation of Phosphorylated Cdc25A | |||||
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.